Janssen Pharmaceutical Companies of Johnson & Johnson announced the approval of ustekinumab as a new treatment option for patients aged 6 years or older with active psoriatic arthritis.
An expert offers considerations and developmentally appropriate interventions to promote high-quality, patient-centered pediatric infusion care.
Investigators suggest parents and clinicians should be mindful of children with suspected ACD with a history of exposure to jewelry, clothing, and belts with cobalt.
At the SPD 2022 47th Annual Meeting, we chat with Albert Yan, MD, of Children's Hospital of Philadelphia on the latest trends in technology for pediatric dermatologists.
At an SPD 2022 47th Annual Meeting poster session, researchers look at gender and age differences in pediatric patients with melanoma.
At the SPD 2022 47th Annual Meeting, a recap of don’t-miss sessions for Sunday, July 10.
Amy Paller, MD, shares key takeaways from her session at the SPD 2022 47th Annual Meeting in Indianapolis.
At the SPD 2022 47th Annual Meeting, a discussion of the latest therapeutics for acne.
At the SPD 2022 47th Annual Meeting in Indianapolis, Indiana, Candrice Heath shares her takeaways "Atopic dermatitis in skin of color."